Iacopo Cappellini | Medicine | Best Researcher Award

Dr. Iacopo Cappellini | Medicine | Best Researcher Award

  University of Florence, Italy

Dr. Iacopo Cappellini  is an experienced Consultant in Anesthesia and Intensive Care with a strong academic and clinical background in critical care medicine. He currently serves in a mixed medical-surgical ICU, with expertise in robotic and laparoscopic surgeries across multiple specialties, including cardiovascular and thoracic anesthesia, organ transplantation, and trauma care.

Profile:

Academic & Research Background:

  • PhD in Anesthesia and Surgical Sciences, University of Florence (2018)
    Thesis: “Diaphragmatic function in Anesthesia and ICU: Role of ultrasonography in assessing postoperative residual curarization”

  • II Level Master’s in Epidemiology and Biostatistics, University of Milano-Bicocca (2021)

  • Over 30 peer-reviewed publications in high-impact journals (PubMed indexed)

  • Co-investigator and author in multiple studies on ECMO, diaphragm ultrasonography, mechanical ventilation, COVID-19 ARDS, and REBOA

  • Visiting Fellowships and Research Appointments in:

    • University of Illinois Chicago

    • Brown University

    • Monash University

    • Mount Sinai Hospital, NY

Key Clinical Experience:

  • Consultant in mixed ICUs (20 beds), advanced anesthesia for:

    • Robotic GI, thoracic, ENT, orthopedic, urology, pediatric surgeries

    • Cardiovascular & thoracic procedures, heart/lung transplants (adult and pediatric)

  • Extensive procedural skills: regional blocks, ECMO/ECCOR, EIT, advanced airway management, echocardiography

  • Emergency Medical Doctor for EMS (Prehospital trauma and ACLS scenarios)

  • Involved in regional organ donation (DBD) protocol development in Tuscany

Publications & Contributions:

  • Over 30 scientific articles including:

    • Anesthesia Research (MDPI), Emergency Care Journal, BMJ Open, Methods and Protocols, Frontiers in Medicine, European Journal of Anesthesiology

  • Recent titles:

    • “Assessment of Visual Function in Patients Undergoing Prone Positioning for COVID-19 ARDS” (2025)

    • “Electrical Impedance Tomography and AI in Respiratory Monitoring” (2024)

    • “Dehumanization in ICUs vs Standard Wards: A Cross-sectional Study” (2024)

  • Contributor to international COVID-19 ICU collaborations (ICU-RER Network)

Certifications & Training:

  • ACLS, PALS, ATLS, ITLS, ABLS, NALS, EPLS certified

  • European Society of Anesthesiology: EDAIC certified

  • Trained in critical care ultrasonography, advanced life support, trauma management

  • Regular faculty for academic anesthesia courses at the University of Florence

Honors and Awards:

  • 🏅 Best Scientific Contribution, 66th National SIAARTI Congress (2012) – for research on KPC outbreak in ICU settings

Technical Proficiency:

  • R, RStudio (biostatistics, machine learning in clinical research)

  • Familiarity with Python ML libraries (scikit-learn, TensorFlow)

  • MS Office, academic databases, CRO collaboration experience

Professional Affiliations:

  • SIAARTI (Italy), ESA (Europe), GMC (UK)

  • Collaborator with Clinical Research Organizations in observational studies (septic shock, ICU outcomes)

Citation Metrics Summary:

  • Total Citations: 467

  • Citing Documents: 448

  • Total Publications: 25

  • h-index: 12

Publication Top Notes:

1. Status of Sepsis Care in European Hospitals: Results from an International Cross-Sectional Survey
American Journal of Respiratory and Critical Care Medicine, 2025
Citations: 2 | Article Type: Review | Access: Open Access

2. Electrical Impedance Tomography, Artificial Intelligence, and Variable Ventilation: Transforming Respiratory Monitoring and Treatment in Critical Care
Journal Name Not Specified, 2025
Citations: 5 | Article Type: Review | Access: Open Access

 

Xu jiancheng | Medicine and Health Sciences | Best Researcher Award

Dr. Xu jiancheng | Medicine and Health Sciences | Best Researcher Award

Professor First Hospital of Jilin University China

Professor Jiancheng Xu (MD, PhD) is a distinguished clinical microbiologist with over 20 years of experience in laboratory medicine. He currently serves as Professor, Doctoral Supervisor, and Deputy Director of the Department of Laboratory Medicine at the First Hospital of Jilin University, China. A joint-training PhD scholar from the University of Louisville, USA, he has made significant contributions to microbiology, diabetic complications, and laboratory diagnostics. He is also a reviewer for several international journals and an influential figure in multiple national medical associations. Outside the lab, he enjoys running and badminton. 🏃‍♂️🏸

Profile

Orcid

🎓 Education

Professor Xu’s academic path reflects a commitment to excellence. He earned his MD from Norman Bethune University of Medical Sciences (1995–2000), followed by an MS in Laboratory Medicine and a PhD in Internal Medicine from Jilin University (2002–2010). He undertook a joint PhD program at the University of Louisville (2008–2009), enhancing his global research exposure. He further completed a postdoctoral fellowship in Laboratory Medicine at China Medical University (2012–2016), solidifying his scientific and clinical foundation. 🎓🧪

💼 Professional Experience

Professor Xu has advanced steadily through academic and clinical ranks. Beginning as a Research Assistant (2000–2006), he became an Attending Physician (2006–2010), Associate Professor (2010–2014), and finally Professor in 2014 at the First Hospital of Jilin University. He currently serves as the Deputy Director of the Department of Laboratory Medicine, mentoring numerous doctoral candidates and leading transformative research. 🧑‍🏫🏥

🔬 Research Interests

Professor Xu’s research spans across vital domains:

  1. 🧠 Mechanism of Diabetic Complications

  2. 🦠 Bacterial Resistance Mechanisms and Surveillance

  3. 📊 Establishment of Reference Intervals for Clinical Tests

  4. 🤖 Disease Prediction Modeling with Machine Learning

  5. 🧬 Trace Element Metabolism in Diabetic Models

His work integrates clinical insights with computational analytics to develop predictive tools and diagnostic advancements in laboratory medicine.

🏆 Awards & Honors

Professor Xu’s outstanding contributions have earned him numerous accolades and appointments:

  • 🏅 Chairman, Society of Laboratory Medicine, Jilin Medical Security Association

  • 🏅 Vice Chairman, Youth Committee, Chinese Society of Laboratory Medicine

  • 🏅 Vice Chairman, Youth Committee, Jilin Medical Association

  • 🏅 Member, Standing Committees across multiple national and provincial laboratory medicine societies

  • 📚 Editorial Board Member, Chinese Journal of Laboratory Medicine

  • 🧪 Reviewer for Biological Trace Element Research, OMICS, and others

He has successfully led over 33 funded research projects, totaling ¥7.04 million RMB.

📚 Publications Top Notes: 

Professor Xu has authored over 125 peer-reviewed articles, with an H-index of 16 and over 1269 citations. His top publications as a corresponding author include:

🧬 A Prognostic Model to Predict Recovery of COVID-19 Patients Based on Longitudinal Laboratory Findings
Virologica Sinica, 2020 – Cited by 39 articles

🧫 The Function of T Follicular Helper Cells in the Autoimmune Liver Diseases
Journal of Immunology Research, 2020 – Cited by 27 articles

🧪 Negative Results in Nucleic Acid Test of COVID-19 Patients: Assessment from Clinical Laboratories
Annals of Palliative Medicine, 2020 – Cited by 18 articles

⚖️ Age- and Sex-Specific Pediatric Reference Intervals of Serum Electrolytes
American Journal of Clinical Pathology, 2020 – Cited by 21 articles

🧫 Laboratory Biosafety Considerations of SARS-CoV-2 at Biosafety Level 2
Health Security, 2020 – Cited by 14 articles

❤️ Changes of Laboratory Cardiac Markers and Mechanisms of Cardiac Injury in COVID-19
BioMed Research International, 2020 – Cited by 33 articles

Resveratrol attenuates testicular apoptosis in type 1 diabetic mice: Role of Akt-mediated Nrf2 activation and p62-dependent Keap1 degradation

Yuchun Wei | Medicine and Health Sciences | Best Researcher Award

Assoc. Prof. Dr. Yuchun Wei | Medicine and Health Sciences | Best Researcher Award

Shandong Cancer Hospital China

Dr. Yuchun Wei is a leading Chinese physician-scientist in the field of oncology and nuclear medicine, currently working at the Shandong Cancer Hospital in Jinan, China. Born on November 22, 1987, she has contributed significantly to developing innovative imaging techniques for cancer diagnosis, staging, and individualized treatment planning. With deep expertise in PET/CT imaging biomarkers, she is committed to advancing precision oncology. 📡🧬

Profile

Scopus

Orcid

🎓 Education

Dr. Wei pursued her academic journey with a strong foundation in both Western and traditional Chinese medicine:

  • Ph.D. in Oncology from Shandong University (2018–2022), mentored by Academician Jinming Yu 🎓
  • Master’s in Oncology from Jinan University (2013–2016), under Prof. Shuanghu Yuan 🔬
  • Bachelor’s in Traditional Chinese and Western Clinical Medicine from Shandong University of Traditional Chinese Medicine (2007–2012) 🌿

💼 Professional Experience

Dr. Wei currently serves as a radiotherapy physician at Shandong Cancer Hospital (2017–present). She has also held several administrative and research leadership roles:

  • Deputy Director, MDT Quality Management Office (2021–2022)
  • Assistant Director, Radioimmunity and Molecular Imaging Room (2020–2021)
    Her clinical expertise is complemented by her operational leadership in multidisciplinary cancer care. 🏥⚕️

🔬 Research Interests

Her research revolves around novel imaging techniques, especially FAPI-based PET/CT imaging, with a focus on early detection, prognosis prediction, and therapy monitoring for cancers such as lung, esophageal, and cervical. Her goal is to refine personalized cancer treatment through quantitative imaging biomarkers. 🔍📊

🏆 Awards & Honors

Dr. Wei has been nominated for multiple research and innovation awards in recognition of her work in molecular imaging and radiation oncology. Her studies have earned significant visibility in top-tier journals (JCR Q1), and she is regarded as a rising star in clinical translational imaging. 🌟

📚 Publications Top Notes: 

Dr. Wei has authored and co-authored over 17 high-impact peer-reviewed papers, most of which appear in JCR Q1 journals. Here are her key publications with direct links and citation highlights:

FAPI Compared with FDG PET/CT for Lung Cancer Diagnosis
Radiology, 2023, IF: 19.7 | Cited by: 33

18F-FAPI PET/CT in Esophageal SCC Response Prediction
J Nucl Med, 2024, IF: 9.1 | Cited by: 12

Early Detection of Radiation-Induced Myocardial Damage
Eur J Nucl Med Mol Imaging, 2023, IF: 10.057 | Cited by: 40

18F-FAPI PET/CT Response in Chemoradiotherapy for ESCC
J Nucl Med, 2023, IF: 11.082 | Cited by: 25

Biodistribution and Targeting of 18F-FAPI-04
Eur J Nucl Med Mol Imaging, 2022, IF: 10.057 | Cited by: 37

Differentiating Lung Cancer Types via PET/CT
Eur J Nucl Med Mol Imaging, 2022, IF: 10.057 | Cited by: 31

Baseline Angiogenesis in NSCLC Prognosis
J Transl Med, 2022, IF: 8.44 | Cited by: 19

Differentiating Inflammatory Lung Lesions with FAPI
Eur Radiol, 2023, IF: 5.9 | Cited by: 10

Comparison Study in Mouse Model using PET Imaging
Sci Rep, 2016, IF: 5.228 | Cited by: 50

Radiation-Induced Lung Damage Model in Rats
Front Oncol, 2022, IF: 5.738 | Cited by: 14